Patrick Campbell

Investigators found that 700 women suffer pregnancy-related deaths every year and 3 of every 5 pregnancy-related deaths were preventable.

Despite less than 2% of patients receiving surgery, they accounted for more than 25% of total expenditures within 1 year of diagnosis.

Using data from the National Health Interview Survey, investigators found major gaps in terms of receiving advice and engaging in diabetes risk-reduction activities.

A recent study found that 33.7% of patients on statins fail to lower their LDL-C to the recommended threshold of 100 mg per dL.

In a recent study, investigators from Europe found using virtual reality technology can have an impact on a patient's quality of life.

Results from the 3-year European Iluvien Registry Safety Study that examined outcomes of the fluocinolone acetonide implant compared to those of the pivotal FAME trials.

After analyzing more than 3700 systematic reviews, investigators found that 1 in 3 were unreliable.

With approval Ruzurgi becomes first treatment for LEMS approved for children.

A recent study found that black patients were far less likely to be prescribed buprenorphine than white patients.

A study presented at ARVO 2019 examines the long-term safety of BAK-free latanoprost for treatment of open-angle glaucoma or ocular hypertension

A recent study, presented at ARVO 2019, found that ophthalmologists have 77% greater odds of experiencing professional fulfillment, but ophthalmology residents are 3 times more likely to express an intent to leave the field than other surgical residents.

A study from ARVO 2019 found that, while optometrists are likely to prescribe them, many are still split over the impact of blue light-blocking devices

Pinakin Davey, DO, PhD, discusses the findings of his study comparing reliability of testing methodologies for visual acuity and contrast sensitivity at ARVO 2019.

Mia Woodward, MD, discusses the findings of her study which explored the possible over prescription and use of opioids post-corneal surgery.

Mia Woodward, MD, discusses her study examining the the inclusion of women and minorities in National Eye Institute clincal trials.

Investigators found that children who experienced concussion-related visual dysfunction had a recovery time nearly twice that of those who did not.

William Freeman, MD, of UCSD and Shiley Eye Institute, discusses the importance of creating treatments for eye diseases that make compliance easier for patients.

William Freeman, MD, discusses the results of a study he led and other potential treatments for geographic atrophy from a session he hosted at ARVO 2019.

Pinakin Davey, DO, PhD, sat down with MD Magazine® at ARVO 2019 to discuss a study he led testing a handheld tonometer for testing IOP.

Jonathan Myers, MD, of the Wills Eye Hospital, discusses a study examining the rate of car accidents among glaucoma patients.

Investigators reported improvements in BCVA and in central subfield thickness, but noted decreases in superficial and deep capillary density.

A recent study found that early intervention before vision loss does little for patients compared to those who do not receive preemptive treatment.

After analyzing information from a cohort of more than 380,000, investigators found an association between chronic illnesses and visual impairment.

Jason Hsu, MD, and his colleagues at the Wills Eye Hospital presented a study at ARVO 2019 regarding short-term outcomes of patients, with nAMD, who switched from afliberecept to ranibizumab.

Mia Woodward, MD, discusses the future of telehealth in ophthalmology and the biggest issues that need to be corrected going forward.

A healthy plant-based diet can reduce a person's risk of developing CKD by 14% and can also help slow the decline of kidney function, according to a new study.

A 27-year study found that signs of oral infections in childhood were associated with cardiovascular risk factors and subclinical atherosclerosis in adulthood.

Investigators found that peanut allergy immunotherapy was associated with a greater risk of anaphylaxis, epinephrine use, and serious adverse events compared to avoidance or placebo.

Investigators examined more than 600 fellow eyes in a secondary analysis to identify 2 imaging features and 1 genetic variant linked to conversion.

Investigators found that 2 months of antibiotic use later in life could result in a 32% increase in likelihood of developing a cardiovascular disease.